Opus genetics phone number
WebSep 23, 2024 · Opus Genetics, a Raleigh startup using gene therapy technology to treat blindness, raises $19 million from investors. The company’s technology was developed at the University of Pennsylvania. WebOct 20, 2024 · RALEIGH – Opus Genetics, which launched in September with $19 million in funding, is adding to the company’s leadership team, the company announced today. Ash Jayagopal, Ph.D., has joined the ...
Opus genetics phone number
Did you know?
WebOpus Genetics Inc. Company Profile Durham, NC Competitors, Financials & Contacts - Dun & Bradstreet. Find company research, competitor information, contact details & financial … WebDec 2, 2024 · Opus Genetics added, Hope in Focus @HopeinFocus1 We have pledged $300,000 by 2025 to support @OpusGeneticswork to …
WebOpus Genetics 8 Davis Drive Suite 220 Durham, NC 27709 For collaborations or partnering inquiries, please contact [email protected]. For media inquiries or to receive news alerts … WebSep 22, 2024 · The University of Pennsylvania also holds equity and licensing interests in Opus Genetics. Media contacts: For The Retinal Degeneration Fund: Jason Menzo 317 …
WebDec 28, 2024 · Opus Genetics is a clinical-stage gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’ venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases. Its AAV-based … WebNov 30, 2024 · Opus Genetics announced an agreement to license its third preclinical program focused on an inherited retinal disease from Massachusetts Eye and Ear, Harvard Medical School’s ophthalmic...
WebAug 20, 2024 · Contact Information Website opusgtx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other …
WebSep 22, 2024 · The company is Opus Genetics, and according to a statement, it will develop “therapies for orphan inherited retinal diseases.” It is backed by $19 million in seed funding from the Retinal ... chx signature bag of 50 d20WebDec 28, 2024 · December 28, 2024 Opus Genetics said it has acquired the rights to two preclinical-stage AAV-based gene therapy product candidates for inherited retinal diseases from Iveric Bio for $500,000 and a “high, single digit” ownership stake in Opus. Photo: Ben Yerxa, CEO of Opus Genetics dfw moving companies reviews and ratingsWebOct 1, 2024 · Jean Bennett, MD, PhD, inventor and co-developer of Luxturna, the first FDA-approved gene therapy, now serves as scientific co-founder and sits on the board of Opus Genetics, founded to ... dfw movies showingWebOpus Genetics has 2 board members and advisors, including Rusty Kelley. Contacts Job Department Search Contacts... Joe Schachle Chief Operating Officer Executive Finance , … dfw moving servicesWebDec 28, 2024 · RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-first gene therapy company developing treatments for inherited retinal diseases, today announced the... chx stain removalWebOpus Genetics is headquartered in Durham, North Carolina. Ben Yerxa is the CEO of Opus Genetics. Opus Genetics has raised a total of $28.5M in funding. Opus Genetics has an … dfw movingWebSep 22, 2024 · The lead programs for Opus Genetics, which is based in North Carolina, are aimed at developing therapeutics that will address mutations in genes that cause different forms of Leber congenital amaurosis (LCA), a group of rare inherited retinal diseases that typically present in infancy and are characterized by degeneration of photoreceptors, the … dfw msa counties